Trailing-twelve-month (TTM) revenue is $21.03 Billion with a year-over-year growth of +14.86%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
Reported statement amounts were converted from EUR to USD using the stored FMP exchange-rate calculation.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $5,012,593,920 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-04 |
| Q4 FY2025Period ended 2025-12-31 | $5,322,067,290 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-10 |
| Q1 FY2026Period ended 2026-03-31 | $5,237,065,560 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-28 |
| Q2 FY2026Period ended 2026-06-30 | $5,460,445,390 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-04 |
| TTM revenue | $21,032,172,160 |
Current P/S: $107,520,539,215 market capitalization ÷ $21,032,172,160 TTM revenue = 5.11x.
Market capitalization source: FMP quote. Quote observed 2026-09-09T20:00:02.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $5.46B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-09T20:00:02.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2024-12-31 · EUR
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · EUR
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20192019-12-31 · EUR | FY20202020-12-31 · EUR | FY20212021-12-31 · EUR | FY20222022-12-31 · EUR | FY20232023-12-31 · EUR | FY20242024-12-31 · EUR |
|---|---|---|---|---|---|---|
| Ad-Supported | EUR 759M | EUR 849M | EUR 1.4B | EUR 1.6B | EUR 1.8B | EUR 2.0B |
| Premium | EUR 6.8B | EUR 8.1B | EUR 10.0B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · EUR | FY20212021-12-31 · EUR | FY20222022-12-31 · EUR | FY20232023-12-31 · EUR | FY20242024-12-31 · EUR | FY20252025-12-31 · EUR |
|---|---|---|---|---|---|---|
| Luxembourg | EUR 6M | EUR 7M | N/A | N/A | N/A | N/A |
| LUXEMBOURG | N/A | N/A |
$21.03B
$21.03 Billion
+14.86%
vs. $18.31B a year ago (TTM)
+15.47%
5 Year compound annual growth rate
1 Year
+14.86%
3 Year
+17.01%
5 Year
+15.47%
10 Year
+25.35%
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $20.19B | +$3.96B | +24.38% |
| 2024 | $16.23B | +$1.61B | +11.00% |
| 2023 | $14.62B | +$2.07B | +16.53% |
| 2022 | $12.55B | +$1.54B | +14.01% |
| 2021 | $11.01B | +$1.38B | +14.33% |
| 2020 |
TTM Growth
+14.86%
3-Year CAGR
+17.01%
5-Year CAGR
+15.47%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 38 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-09T20:00:02.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| EUR 12.5B |
| EUR 14.9B |
| N/A |
| EUR 10M |
| EUR 13M |
| Other Countries | EUR 4.7B | EUR 5.9B | EUR 5.9B | EUR 6.8B | EUR 8.0B | EUR 10.7B |
|---|
| United Kingdom | EUR 953M | EUR 1.2B | N/A | N/A | N/A | N/A |
|---|
| United States | EUR 3.4B | EUR 4.4B | N/A | N/A | N/A | N/A |
|---|
| UNITED STATES | N/A | N/A | EUR 4.7B | EUR 5.2B | EUR 6.1B | EUR 6.5B |
|---|
| $9.63B |
| +$2.04B |
| +26.81% |
| 2019 | $7.59B | +$1.57B | +26.12% |
| 2018 | $6.02B | +$1.11B | +22.58% |
| 2017 | $4.91B | +$1.81B | +58.14% |
| 2016 | $3.10B | +$997.28M | +47.32% |
